Another study showed that a bs-Ab targeting TNF-α and IL-6 (TNF-α × IL-6)successfully inhibited CXCR-13 activity in both in vitro and in vivo models of rheumatoid arthritis [327]. This evidence concerns the gene IL6 and rheumatoid arthritis.